Gyre Therapeutics Inc. (GYRE)
NASDAQ · Healthcare
Gyre Therapeutics Inc. Total Liabilities 2009–2025
Gyre Therapeutics Inc. annual total liabilities history from 2010 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Gyre Therapeutics Inc. total liabilities as of December 31, 2025: 23.9M, a 11.68% decrease year-over-year.
- Gyre Therapeutics Inc. total liabilities for 2025 were 23.9M, a 11.68% decrease from 2024.
- Gyre Therapeutics Inc. total liabilities for 2024 were 27.0M, a 29.06% decrease from 2023.
- Gyre Therapeutics Inc. total liabilities for 2023 were 38.1M, a 203.65% increase from 2022.
- Gyre Therapeutics Inc. total liabilities for 2022 were 12.5M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Gyre Therapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $24 |
| 2024 | $27 |
| 2023 | $38 |
| 2022 | $13 |
| 2021 | $15 |
| 2020 | $19 |
| 2018 | $5 |
| 2017 | $9 |
| 2014 | $3 |
| 2013 | $11 |
| 2012 | $14 |
| 2011 | $84 |
| 2010 | $171 |
Gyre Therapeutics Inc. Total Liabilities — FAQ
Gyre Therapeutics Inc. (GYRE) total liabilities over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see GYRE's total liabilities history?
The chart and table above show Gyre Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.